[INQ. NO. 2203E02] Since its founding in 1997 in Korea, where laser medical devices were almost nonexistent, Lutronic has been striving to achieve its goal of improving the quality of human life.
Smart laser device R:GEN is a medical device targeting the retina that is located in the innermost, light-sensitive layer of tissue of the eye.
Unlike other laser treatments that damage the entire retina, it selectively targets only the retinal pigment epithelial (RPE) layer, helping to treat it and surrounding tissue such as visual cells by minimizing damage.
It has been approved for Diabetic Macular Edema (DME) and Central Serous Chorioretinopathy (CSC) in Korea and Europe. Also Clinically Significant Macular Edema (CSME) has proven its safety and effectiveness by obtaining FDA approval in the United States.
Non-invasive Medical Device
CoreLevee is a non-invasive medical device for relieving muscular pain through an applicator that uses medical electromagnetic field technology. It provides four sophisticated programs to each of the treatment parts, and features excellent control of intensity from mild stimulation.
The applicator with independent stimulation control enables accurate treatment for each customer. It also provides effective treatment by maximizing the convenience of the procedure.
Over the past 24 years, Lutronic has grown into one of the top-10 global companies in this field with overseas subsidiaries, including in the USA and Germany, by pioneering and accumulating technology focused on consistent clinical excellence and developing in-house production capacity.
With 30% of its headquarters staff focusing on research and development, Lutronic is continuously developing and introducing new products to lead the global market. In addition, it has been recognized for safety and effectiveness by acquiring country-specific certifications such as the U.S. FDA and European Union’s CE – based on its long-standing know-how and technology.
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods
Leave a Reply